Unprecedented Sesterterpenoids Orientanoids A‒C: Discovery, Bioinspired Total Synthesis and Antitumor Immunity

11 July 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Sesterterpenoids are a very rare class of important natural products. Three new skeletal spiro sesterterpenoids, named orientanoids A–C (1–3), were isolated from Hedyosmum orientale. Their structures were determined by a combination of spectroscopic data, X-ray crystallography, and total synthesis. To obtain adequate materials for biological research, the bioinspired total syntheses of 1–3 were effectively achieved in 7–8 steps in the overall yields of 2.3–6.4% from the commercially available santonin without using any protecting groups and transition-metal catalysts, which mimicked their biosynthetic proposal chemically. In addition, this work also revised hedyosumins B (7) and C (8) as 11R-configuration. Tumor-associated macrophages (TAMs) have emerged as important therapeutic targets in cancer therapy. The in-depth biological evaluation revealed that these sesterterpenoids antagonized the protumoral and immunosuppressive functional phenotype of macrophages in vitro. Among them, the most potent and major compound 1 inhibited protumoral M2-like macrophages and activated cytotoxic CD8+ T cells, and consequently contained tumor growth in vivo.

Keywords

Sesterterpenoids
Orientanoids A‒C
Structural Elucidation
Bioinspired Synthesis
Antitumor Immunity

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.